FERMT3 and breast cancer: Kindlin-3 was over-expressed in both breast cancer cell lines and primary tumors, which is consistent with several Oncomine (www.oncomine.com) datasets, where kindlin-3 was in the top 3% of gene products elevated in breast cancer (p< 10-12)56.